These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32738178)

  • 21. Role of PECAM-1 in the adherence of PMN to hypoxic endothelial cells.
    Michiels C; Arnould T; Remacle J
    Cell Adhes Commun; 1998 Jul; 5(5):367-74. PubMed ID: 9789684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissociation between alveolar transmigration of neutrophils and lung injury in hyperoxia.
    Perkowski S; Scherpereel A; Murciano JC; Arguiri E; Solomides CC; Albelda SM; Muzykantov V; Christofidou-Solomidou M
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L1050-8. PubMed ID: 16815892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats.
    Carlos TM; Clark RS; Franicola-Higgins D; Schiding JK; Kochanek PM
    J Leukoc Biol; 1997 Mar; 61(3):279-85. PubMed ID: 9060450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of insulin-like growth factor 1 on PECAM-1 and ICAM-1 adhesion molecules expression in tumor necrosis factor alpha and hyperglycemia induced umbilical vein endothelial cells].
    Wnuczko K; Szczepański M
    Wiad Lek; 2008; 61(4-6):119-25. PubMed ID: 18939362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1.
    Muro S; Dziubla T; Qiu W; Leferovich J; Cui X; Berk E; Muzykantov VR
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1161-9. PubMed ID: 16505161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of vascular targeted monoclonal antibody.
    Kennel SJ; Huang Y; Zeng WB; Stuckey A; Wall J
    Curr Drug Deliv; 2010 Dec; 7(5):428-35. PubMed ID: 20950267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration.
    Liu G; Place AT; Chen Z; Brovkovych VM; Vogel SM; Muller WA; Skidgel RA; Malik AB; Minshall RD
    Blood; 2012 Aug; 120(9):1942-52. PubMed ID: 22806890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells.
    Xenos ES; Stevens SL; Freeman MB; Cassada DC; Goldman MH
    Ann Vasc Surg; 2005 May; 19(3):386-92. PubMed ID: 15818460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) in murine tissues.
    Eppihimer MJ; Russell J; Langley R; Vallien G; Anderson DC; Granger DN
    Microcirculation; 1998; 5(2-3):179-88. PubMed ID: 9789258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting.
    Greineder CF; Villa CH; Walsh LR; Kiseleva RY; Hood ED; Khoshnejad M; Warden-Rothman R; Tsourkas A; Muzykantov VR
    Bioconjug Chem; 2018 Jan; 29(1):56-66. PubMed ID: 29200285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.
    Muzykantov VR; Christofidou-Solomidou M; Balyasnikova I; Harshaw DW; Schultz L; Fisher AB; Albelda SM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2379-84. PubMed ID: 10051650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs.
    Christofidou-Solomidou M; Pietra GG; Solomides CC; Arguiris E; Harshaw D; Fitzgerald GA; Albelda SM; Muzykantov VR
    Am J Physiol Lung Cell Mol Physiol; 2000 Apr; 278(4):L794-805. PubMed ID: 10749757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells.
    Calderon AJ; Muzykantov V; Muro S; Eckmann DM
    Biorheology; 2009; 46(4):323-41. PubMed ID: 19721193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery.
    Dan M; Cochran DB; Yokel RA; Dziubla TD
    PLoS One; 2013; 8(11):e81051. PubMed ID: 24278373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: use of an optimized procedure for the coupling of low concentrations of antibody to liposomes.
    Hua S; Chang HI; Davies NM; Cabot PJ
    J Liposome Res; 2011 Jun; 21(2):95-105. PubMed ID: 20429814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra- and trans-cellular delivery of enzymes by direct conjugation with non-multivalent anti-ICAM molecules.
    Ghaffarian R; Roki N; Abouzeid A; Vreeland W; Muro S
    J Control Release; 2016 Sep; 238():221-230. PubMed ID: 27473764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers.
    Muro S; Garnacho C; Champion JA; Leferovich J; Gajewski C; Schuchman EH; Mitragotri S; Muzykantov VR
    Mol Ther; 2008 Aug; 16(8):1450-8. PubMed ID: 18560419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor.
    Papademetriou J; Garnacho C; Serrano D; Bhowmick T; Schuchman EH; Muro S
    J Inherit Metab Dis; 2013 May; 36(3):467-77. PubMed ID: 22968581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.
    Shuvaev VV; Christofidou-Solomidou M; Scherpereel A; Simone E; Arguiri E; Tliba S; Pick J; Kennel S; Albelda SM; Muzykantov VR
    J Control Release; 2007 Apr; 118(2):235-44. PubMed ID: 17270308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy.
    Li S; Chen L; Wang G; Xu L; Hou S; Chen Z; Xu X; Wang X; Liu F; Du YZ
    J Nanobiotechnology; 2018 Dec; 16(1):105. PubMed ID: 30594254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.